What is Senderra?
Senderra operates as a national specialty pharmacy, dedicated to providing essential specialty medications, clinical expertise, and comprehensive support services. The company's model is designed to address the intricate needs of patients, prescribers, pharmaceutical companies, and payers, aiming to effect positive health outcomes and streamline care delivery for challenging medical conditions.
How much funding has Senderra raised?
Senderra has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Senderra
PPP
Public-Private Partnership
What's next for Senderra?
The recent major strategic investment signals a new phase of growth and operational expansion for Senderra. This capital is expected to fuel advancements in service offerings, enhance patient support programs, and potentially broaden the company's reach within the specialty pharmacy market. The enterprise-level funding context suggests a focus on scaling operations and solidifying its position as a key player in managing chronic and complex diseases through specialized pharmaceutical solutions.
See full Senderra company page
